心脉医疗：累计回购约133万股

Group 1 - The company, Xinmai Medical, announced its first share buyback on December 6, 2024, through centralized bidding, completing the buyback by October 27, 2025 [1] - A total of approximately 1.33 million shares were repurchased, accounting for 1.08% of the company's total share capital, with a maximum transaction price of 120 CNY per share and a minimum of 84.26 CNY per share, resulting in an average buyback price of 105.03 CNY per share [1] - The total funds used for the buyback amounted to approximately 140 million CNY, reaching the lower limit of the buyback plan without exceeding the upper limit [1] Group 2 - For the year 2024, Xinmai Medical's revenue composition indicates that 99.7% of its revenue comes from products related to aortic and peripheral vascular applications, while other businesses contribute only 0.3% [1] - As of the report date, the market capitalization of Xinmai Medical is 12.8 billion CNY [1]